Skip to main content
Premium Trial:

Request an Annual Quote

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died, the Washington Post reports. He was 91.

Choppin led HHMI for 12 years and developed its investigator program, it adds. Through the investigator program, HHMI directly employs medical researchers at different universities around the US on seven-year, renewable contracts and, according to the Post, Choppin came up with the "people, not projects" slogan to describe the institute's approach. "We bet on people who look like they are going to be winners," Choppin once told the Post. "You look for originality. How they pick a problem and stick to it. Their instinct for the scientific jugular."

In his own work, Choppin studied viral replication and how viruses attach to cells, focusing on influenza and measles viruses, though the New York Times notes that his research and methods has also contributed to the understanding of SARS-CoV-2.

"Not only was Purnell a giant in the field of virology, his contributions to the entire biomedical research community are profound," Francis Collins, the director of the National Institutes of Health, says in a statement, according to the Post. "I had the good fortune of being an HHMI investigator under his leadership and benefited on numerous occasions from his wisdom and sage advice."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.